SMPDL3B activators encompass a diverse class of chemicals designed to modulate the activity of the enzyme sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B). This enzyme is implicated in the metabolism of sphingolipids, a class of lipids known to play a critical role in cell membrane structure and signaling. SMPDL3B is thought to influence not only lipid metabolism but also cell membrane dynamics and potentially, signal transduction pathways related to sphingolipid functions.
Direct activators of SMPDL3B would typically engage with the enzyme to enhance its catalytic action, facilitating the hydrolysis of sphingomyelin to ceramide and phosphocholine. The mechanism of such direct activation could involve binding to the active site of SMPDL3B or to allosteric sites that, upon interaction, induce a conformational change resulting in an increased affinity for substrate or a higher turnover rate. These changes could modulate the SMPDL3B activity, thereby regulating the levels of bioactive sphingolipids within the cell. Indirect activators might work by increasing the expression levels of SMPDL3B, either through upregulating gene transcription or by stabilizing the mRNA to boost protein synthesis. They may also act by preventing the degradation of the enzyme, thus prolonging its presence and function within the cell. Another indirect method of activation might involve the modulation of cellular signaling pathways that control the post-translational modification of SMPDL3B, such as phosphorylation, which can affect the enzyme's activity, stability, and interactions with other cellular components.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sebacic acid | 111-20-6 | sc-215843 sc-215843A | 100 g 250 g | $20.00 $35.00 | ||
Sphingosine is a precursor of sphingomyelin and can enhance the activity of SMPDL3B by providing more substrate for its sphingomyelinase activity. This leads to an increase in the production of ceramide, a known modulator of many cellular processes. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 is an inhibitor of ceramide synthase. By blocking this pathway, it can enhance the activity of SMPDL3B by increasing the availability of sphingosine, the substrate of SMPDL3B, for conversion to ceramide. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
Myriocin is an inhibitor of serine palmitoyltransferase, which is involved in the de novo synthesis of ceramide. By inhibiting this pathway, it increases the availability of sphingosine for SMPDL3B, enhancing its activity. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
D609 is a potent inhibitor of phosphatidylcholine-specific phospholipase C. Its action leads to the accumulation of phosphatidylcholine, which can be converted to sphingomyelin, the substrate of SMPDL3B, thereby enhancing its activity. | ||||||
Sphingomyelin | 85187-10-6 | sc-201381 sc-201381A | 100 mg 500 mg | $180.00 $560.00 | 3 | |
Sphingomyelin is a direct substrate of SMPDL3B. Increasing the availability of sphingomyelin can enhance the enzymatic activity of SMPDL3B leading to the production of ceramide. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an inhibitor of tyrosine kinases which can influence the sphingolipid metabolism. By inhibiting these enzymes, it can increase the availability of sphingomyelin, the substrate for SMPDL3B, thereby enhancing its activity. | ||||||